HuGE Literature Finder
Records 1-100
|
Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study.
BMC cancer 2019 Aug 19 (1): 772. Casula Milena, Paliogiannis Panagiotis, Ayala Fabrizio, De Giorgi Vincenzo, Stanganelli Ignazio, Mandalà Mario, Colombino Maria, Manca Antonella, Sini Maria Cristina, Caracò Corrado, Ascierto Paolo Antonio, Satta Rosanna Rita, , Lissia Amelia, Cossu Antonio, Palmieri Giuseppe, |
|
Clinical mutational profiling and categorization of BRAF mutations in melanomas using next generation sequencing.
BMC cancer 2019 Jul 19 (1): 665. Lokhandwala Parvez M, Tseng Li-Hui, Rodriguez Erika, Zheng Gang, Pallavajjalla Aparna, Gocke Christopher D, Eshleman James R, Lin Ming-Ts |
|
Clinicopathological characteristics and mutation profile of BRAF and NRAS mutation in
cutaneous melanomas in the Western Turkish population
Turkish journal of medical sciences 2018 Oct 48 (5): 973-979. Evrenos Mustafa Kürsat, Temiz Peyker, Çam Fethi Sirri, Yaman Murat, Yoleri Levent, Ermertcan Aylin Tür |
|
Predictive genetic profiles for regional lymph node metastasis in primary cutaneous melanoma: a case-matched pilot study.
Melanoma research 2018 Sep . Nye Anthony, Collins Justin D, Porter Caroline L, Montes de Oca Mary, George Kathryn, Stafford Colin G, Schammel Christine M G, Horton Samuel, Trocha Steven |
|
SF3B1, NRAS, KIT, and BRAF Mutation; CD117 and cMYC Expression; and Tumoral Pigmentation in Sinonasal Melanomas: An Analysis With Newly Found Molecular Alterations and Some Population-based Molecular Differences.
The American journal of surgical pathology 2018 Sep . Wroblewska Joanna P, Mull Jason, Wu Cheng-Lin, Fujimoto Masakazu, Ogawa Toru, Marszalek Andrzej, Hoang Mai |
|
TERT promoter mutation subtypes and survival in stage I and II melanoma patients.
International journal of cancer 2018 Aug . Andrés-Lencina Juan J, Rachakonda Sivaramakrishna, García-Casado Zaida, Srinivas Nalini, Skorokhod Alexander, Requena Celia, Soriano Virtudes, Kumar Rajiv, Nagore Eduar |
|
Female genitourinary tract melanoma: mutation analysis with clinicopathologic correlation: a single-institution experience.
Melanoma research 2018 Jul . Saglam Ozlen, Naqvi Syeda M H, Zhang Yonghong, Mesa Tania, Teer Jamie K, Yoder Sean, Lee Jae, Messina Ja |
|
Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes.
The Journal of investigative dermatology 2018 May . Thomas Nancy E, Edmiston Sharon N, Orlow Irene, Kanetsky Peter A, Luo Li, Gibbs David C, Parrish Eloise A, Hao Honglin, Busam Klaus J, Armstrong Bruce K, Kricker Anne, Cust Anne E, Anton-Culver Hoda, Gruber Stephen B, Gallagher Richard P, Zanetti Roberto, Rosso Stefano, Sacchetto Lidia, Dwyer Terence, Ollila David W, Begg Colin B, Berwick Marianne, Conway Kathleen, |
|
?-Catenin-mediated immune evasion pathway frequently operates in primary cutaneous melanomas.
The Journal of clinical investigation 2018 Apr . Nsengimana Jérémie, Laye Jon, Filia Anastasia, O'Shea Sally, Muralidhar Sathya, Po?niak Joanna, Droop Alastair, Chan May, Walker Christy, Parkinson Louise, Gascoyne Joanne, Mell Tracey, Polso Minttu, Jewell Rosalyn, Randerson-Moor Juliette, Cook Graham P, Bishop D Timothy, Newton-Bishop Jul |
|
Prevalence of BRAF, NRAS and c-KIT mutations in Slovenian patients with advanced melanoma.
Radiology and oncology 2018 Apr 52 (3): 289-295. Moltara Maja Ebert, Novakovic Srdjan, Boc Marko, Bucic Marina, Rebersek Martina, Zadnik Vesna, Ocvirk Jan |
|
Concordance of somatic mutational profile in multiple primary melanomas.
Pigment cell & melanoma research 2018 Mar . Adler Nikki R, McLean Catriona A, Wolfe Rory, Kelly John W, McArthur Grant A, Haydon Andrew, Tra Thien, Cummings Nicholas, Mar Victoria |
|
Appendiceal goblet cell carcinoids and adenocarcinomas ex-goblet cell carcinoid are genetically distinct from primary colorectal-type adenocarcinoma of the appendix.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2018 Jan . Jesinghaus Moritz, Konukiewitz Björn, Foersch Sebastian, Stenzinger Albrecht, Steiger Katja, Muckenhuber Alexander, Groß Claudia, Mollenhauer Martin, Roth Wilfried, Detlefsen Sönke, Weichert Wilko, Klöppel Günter, Pfarr Nicole, Schlitter Anna Melis |
|
Genetic Alterations among Korean Melanoma Patients Showing Tumor Heterogeneity: A Comparison between Primary Tumors and Corresponding Metastatic Lesions.
Cancer research and treatment : official journal of Korean Cancer Association 2018 Jan . Lee Si-Hyung, Kim Jee Eun, Jang Hong Sun, Park Kyu Hyun, Oh Byung Ho, Shin Sang Joon, Chung Kee Yang, Roh Mi Ryung, Rha Sun You |
|
Genetic Background of Iris Melanomas and Iris Melanocytic Tumors of Uncertain Malignant Potential.
Ophthalmology 2018 Jan . van Poppelen Natasha M, Vaarwater Jolanda, Mudhar Hardeep S, Sisley Karen, Rennie Ian G, Rundle Paul, Brands Tom, van den Bosch Quincy C C, Mensink Hanneke W, de Klein Annelies, Kiliç Emine, Verdijk Robert |
|
BRAF mutations might be more common than supposed in vulvar melanomas.
Experimental dermatology 2018 02 27 (2): 210-213. Wylomanski Sophie, Denis Marc G, Théoleyre Sandrine, Bouquin Réjane, Vallée Audrey, Knol Anne-Chantal, Saint-Jean Mélanie, Peuvrel Lucie, Dréno Brigitte, Quéreux Gaël |
|
Feasibility of monitoring advanced melanoma patients using cell-free DNA from plasma.
Pigment cell & melanoma research 2018 01 31 (1): 73-81. Gangadhar Tara C, Savitch Samantha L, Yee Stephanie S, Xu Wei, Huang Alexander C, Harmon Shannon, Lieberman David B, Soucier Devon, Fan Ryan, Black Taylor A, Morrissette Jennifer J D, Salathia Neeraj, Waters Jill, Zhang Shile, Toung Jonathan, van Hummelen Paul, Fan Jian-Bing, Xu Xiaowei, Amaravadi Ravi K, Schuchter Lynn M, Karakousis Giorgos C, Hwang Wei-Ting, Carpenter Erica |
|
Circulating tumor DNA predicts survival in patients with resected high risk stage II/III melanoma.
Annals of oncology : official journal of the European Society for Medical Oncology 2017 Nov . Lee R J, Gremel G, Marshall A, Myers K A, Fisher N, Dunn J, Dhomen N, Corrie P G, Middleton M R, Lorigan P, Marais |
|
Dermoscopy and confocal microscopy for metachronous multiple melanomas: morphological, clinical, and molecular correlations.
European journal of dermatology : EJD 2017 Nov . Colombino Maria, Paliogiannis Panagiotis, Pagliarello Calogero, Cossu Antonio, Lissia Amelia, Satta Rosanna, Mazzoni Laura, Magi Serena, Sini Maria Cristina, Manca Antonella, Casula Milena, Doneddu Valentina, Palmieri Giuseppe, Stanganelli Ignaz |
|
Genetic Alterations in Primary Acral Melanoma and Acral Melanocytic Nevus in Korea: Common Mutated Genes Show Distinct Cytomorphological Features.
The Journal of investigative dermatology 2017 Nov . Moon Ki Rang, Choi Yoo Duk, Kim Jung Min, Jin Suna, Shin Min-Ho, Shim Hyun-Jeong, Lee Jee-Bum, Yun Sook Ju |
|
Heterogeneity Of Braf, Nras, And Tert-Promoter Mutational Status In Multiple Melanomas And Association With Mc1r Genotype: Findings From Molecular And Immunohistochemical Analysis.
The Journal of molecular diagnostics : JMD 2017 Oct . Pellegrini Cristina, Di Nardo Lucia, Cipolloni Gianluca, Martorelli Claudia, De Padova Marina, Antonini Ambra, Maturo Maria Giovanna, Del Regno Laura, Strafella Sara, Micantonio Tamara, Leocata Pietro, Peris Ketty, Fargnoli Maria Concet |
|
Associations of MC1R genotype and patient phenotypes with BRAF and NRAS mutations in melanoma.
The Journal of investigative dermatology 2017 Aug . Thomas Nancy E, Edmiston Sharon N, Kanetsky Peter A, Busam Klaus J, Kricker Anne, Armstrong Bruce K, Cust Anne E, Anton-Culver Hoda, Gruber Stephen B, Luo Li, Orlow Irene, Reiner Anne S, Gallagher Richard P, Zanetti Roberto, Rosso Stefano, Sacchetto Lidia, Dwyer Terence, Parrish Eloise A, Hao Honglin, Gibbs David C, Frank Jill S, Ollila David W, Begg Colin B, Berwick Marianne, Conway Kathleen, |
|
Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care.
BMC cancer 2017 Aug 17 (1): 536. Heppt Markus V, Siepmann Timo, Engel Jutta, Schubert-Fritschle Gabriele, Eckel Renate, Mirlach Laura, Kirchner Thomas, Jung Andreas, Gesierich Anja, Ruzicka Thomas, Flaig Michael J, Berking Caro |
|
The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain Metastases.
International journal of radiation oncology, biology, physics 2017 Aug 98 (5): 1069-1077. Sperduto Paul W, Jiang Wen, Brown Paul D, Braunstein Steve, Sneed Penny, Wattson Daniel A, Shih Helen A, Bangdiwala Ananta, Shanley Ryan, Lockney Natalie A, Beal Kathryn, Lou Emil, Amatruda Thomas, Sperduto William A, Kirkpatrick John P, Yeh Norman, Gaspar Laurie E, Molitoris Jason K, Masucci Laura, Roberge David, Yu James, Chiang Veronica, Mehta Mine |
|
Frequent GNAQ, GNA11, and EIF1AX Mutations in Iris Melanoma.
Investigative ophthalmology & visual science 2017 Jul 58 (9): 3464-3470. Scholz Simone L, Möller Inga, Reis Henning, Süßkind Daniela, van de Nes Johannes A P, Leonardelli Sonia, Schilling Bastian, Livingstone Elisabeth, Schimming Tobias, Paschen Annette, Sucker Antje, Murali Rajmohan, Steuhl Klaus-Peter, Schadendorf Dirk, Westekemper Henrike, Griewank Klaus |
|
Variation of mutant allele frequency in NRAS Q61 mutated melanomas.
BMC dermatology 2017 Jul 17 (1): 9. Hélias-Rodzewicz Zofia, Funck-Brentano Elisa, Terrones Nathalie, Beauchet Alain, Zimmermann Ute, Marin Cristi, Saiag Philippe, Emile Jean-Franço |
|
Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations.
Oncotarget 2017 Jun 8 (25): 40683-40692. Cosgarea Ioana, Ugurel Selma, Sucker Antje, Livingstone Elisabeth, Zimmer Lisa, Ziemer Mirjana, Utikal Jochen, Mohr Peter, Pfeiffer Christiane, Pföhler Claudia, Hillen Uwe, Horn Susanne, Schadendorf Dirk, Griewank Klaus G, Roesch Alexand |
|
Clinicopathological characteristics of thyroid cancer in the federal state of Salzburg.
Wiener klinische Wochenschrift 2017 May . Rendl Gundula, Rodrigues Margarida, Schweighofer-Zwink Gregor, Hutter Josef, Hittmair Anton, Zellinger Barbara, Hauser-Kronberger Cornelia, Pirich Christi |
|
Mutation status among patients with sinonasal mucosal melanoma and its impact on survival.
British journal of cancer 2017 May . Amit Moran, Tam Samantha, Abdelmeguid Ahmed S, Roberts Dianna B, Takahashi Yoko, Raza Shaan M, Su Shirley Y, Kupferman Michael E, DeMonte Franco, Hanna Ehab |
|
Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients.
British journal of cancer 2017 Feb . Malapelle Umberto, Mayo de-Las-Casas Clara, Rocco Danilo, Garzon Monica, Pisapia Pasquale, Jordana-Ariza Nuria, Russo Maria, Sgariglia Roberta, De Luca Caterina, Pepe Francesco, Martinez-Bueno Alejandro, Morales-Espinosa Daniela, González-Cao María, Karachaliou Niki, Viteri Ramirez Santiago, Bellevicine Claudio, Molina-Vila Miguel Angel, Rosell Rafael, Troncone Giancar |
|
Mutational Status of NRAS and BRAF Genes and Protein Expression Analysis in a Series of Primary Oral Mucosal Melanoma.
The American Journal of dermatopathology 2017 Feb 39 (2): 104-110. Hsieh Ricardo, Nico Marcello M S, Camillo Cláudia M C, Oliveira Kátia K, Sangueza Martin, Lourenço Silvia |
|
Detection of Rare Mutations by Routine Analysis of KRAS, NRAS, and BRAF Oncogenes.
Bulletin of experimental biology and medicine 2017 Jan 162 (3): 375-378. Mikhailenko D S, Efremov G D, Safronova N Yu, Strelnikov V V, Alekseev B |
|
Comparative study on driver mutations in primary and metastatic melanomas at a single Japanese institute: A clue for intra- and inter-tumor heterogeneity.
Journal of dermatological science 2016 Oct . Kaji Tatsuya, Yamasaki Osamu, Takata Minoru, Otsuka Masaki, Hamada Toshihisa, Morizane Shin, Asagoe Kenji, Yanai Hiroyuki, Hirai Yoji, Umemura Hiroshi, Iwatsuki Kei |
|
NRAS and EPHB6 mutation rates differ in metastatic melanomas of patients in the North Island versus South Island of New Zealand.
Oncotarget 2016 Jul 7 (27): 41017-41030. Jones Angela M, Ferguson Peter, Gardner Jacqui, Rooker Serena, Sutton Tim, Ahn Antonio, Chatterjee Aniruddha, Bickley Vivienne M, Sarwar Makhdoom, Emanuel Patrick, Kenwright Diane, Shepherd Peter R, Eccles Michael |
|
High TERT promoter mutation frequency in non-acral cutaneous metastatic melanoma.
Pigment cell & melanoma research 2016 Jun . Ekedahl Henrik, Lauss Martin, Olsson Håkan, Griewank Klaus G, Schadendorf Dirk, Ingvar Christian, Jönsson Gör |
|
Multi-region whole-exome sequencing uncovers the genetic evolution and mutational heterogeneity of early-stage metastatic melanoma.
Cancer research 2016 May . Harbst Katja, Lauss Martin, Cirenajwis Helena, Isaksson Karolin, Rosengren Frida, Torngren Therese, Kvist Anders, Johansson Maria C, Vallon-Christersson Johan, Baldetorp Bo, Borg Ake, Olsson Håkan, Ingvar Christian, Carneiro Ana, Jonsson Gor |
|
Comparative analysis of the GNAQ, GNA11, SF3B1, and EIF1AX driver mutations in melanoma and across the cancer spectrum.
Pigment cell & melanoma research 2016 Apr . Johnson Douglas B, Roszik Jason, Shoushtari Alexander N, Eroglu Zeynep, Balko Justin, Higham Catherine, Puzanov Igor, Patel Sapna P, Sosman Jeffrey A, Woodman Scott |
|
Increase in NRAS mutant allele percentage during metastatic melanoma progression.
Experimental dermatology 2016 Mar . Funck-Brentano Elisa, Hélias-Rodzewicz Zofia, Longvert Christine, Mokhtari Karima, Saiag Philippe, Emile Jean-Franço |
|
PARKIN Inactivation Links Parkinson's Disease to Melanoma.
Journal of the National Cancer Institute 2016 Mar 108 (3): . Hu Hui-Han, Kannengiesser Caroline, Lesage Suzanne, André Jocelyne, Mourah Samia, Michel Laurence, Descamps Vincent, Basset-Seguin Nicole, Bagot Martine, Bensussan Armand, Lebbé Céleste, Deschamps Lydia, Saiag Philippe, Leccia Marie-Thérèse, Bressac-de-Paillerets Brigitte, Tsalamlal Amel, Kumar Rajiv, Klebe Stephan, Grandchamp Bernard, Andrieu-Abadie Nathalie, Thomas Luc, Brice Alexis, Dumaz Nicolas, Soufir Nad |
|
Promoter Methylation of PTEN is a Significant Prognostic Factor in Melanoma Survival.
The Journal of investigative dermatology 2016 Feb . Roh Mi Ryung, Gupta Sameer, Park Kyu-Hyun, Chung Kee Yang, Lauss Martin, Flaherty Keith T, Jönsson Göran, Rha Sun Young, Tsao Hens |
|
TERT promoter mutations in melanoma survival.
International journal of cancer. Journal international du cancer 2016 Feb . Nagore Eduardo, Heidenreich Barbara, Rachakonda Sívaramakrishna, Garcia-Casado Zaida, Requena Celia, Soriano Virtudes, Frank Christoph, Traves Victor, Quecedo Esther, Sanjuan-Gimenez Josefa, Hemminki Kari, Teresa Landi Maria, Kumar Raj |
|
The molecular profile of metastatic melanoma in Australia.
Pathology 2016 Feb 48 (2): 188-93. Lyle Megan, Haydu Lauren E, Menzies Alexander M, Thompson John F, Saw Robyn P M, Spillane Andrew J, Kefford Richard F, Mann Graham J, Cooper Wendy A, Yu Bing, Scolyer Richard A, O'Toole Sandra A, Long Georgina |
|
Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms.
European journal of cancer (Oxford, England : 1990) 2015 Dec 51 (18): 2792-9. Johnson Douglas B, Menzies Alexander M, Zimmer Lisa, Eroglu Zeynep, Ye Fei, Zhao Shilin, Rizos Helen, Sucker Antje, Scolyer Richard A, Gutzmer Ralf, Gogas Helen, Kefford Richard F, Thompson John F, Becker Jürgen C, Berking Carola, Egberts Friederike, Loquai Carmen, Goldinger Simone M, Pupo Gulietta M, Hugo Willy, Kong Xiangju, Garraway Levi A, Sosman Jeffrey A, Ribas Antoni, Lo Roger S, Long Georgina V, Schadendorf Di |
|
Analysis of somatic mutations in braf, CDKN2A/p16 and PI3KCA in patients with medullary thyroid carcinoma.
Molecular medicine reports 2015 Dec . Nascimento Fabrício P, Cardoso Mirian G, Lindsey Susan C, Kunii Ilda S, Valente Flávia O F, Kizys Marina M L, Delcelo Rosana, Camacho Cléber P, Maciel Rui M B, Dias-Da-Silva Magnus |
|
Varying Mutational Alterations in Multiple Primary Melanomas.
The Journal of molecular diagnostics : JMD 2015 Nov . Egberts Friederike, Bohne Ann-Sophie, Krüger Sandra, Hedderich Jürgen, Rompel Rainer, Haag Jochen, Röcken Christoph, Hauschild Ax |
|
Disease kinetics but not disease burden is relevant for survival in melanoma of unknown primary tumor.
Discovery medicine 2015 Oct 20 (110): 231-7. Heppt Markus V, Tietze Julia K, Reinholz Markus, Rahimi Farnaz, Jung Andreas, Kirchner Thomas, Ruzicka Thomas, Flaig Michael J, Berking Caro |
|
FOXP3+ T regulatory lymphocytes in primary melanoma are associated with BRAF mutation but not with response to BRAF inhibitor.
Pathology 2015 Oct 47 (6): 557-63. Leslie Connull, Bowyer Samantha E, White Alison, Grieu-Iacopetta Fabienne, Trevenen Michelle, Iacopetta Barry, Amanuel Benhur, Millward Micha |
|
NF1 Mutations Are Common in Desmoplastic Melanoma.
The American journal of surgical pathology 2015 Oct 39 (10): 1357-62. Wiesner Thomas, Kiuru Maija, Scott Sasinya N, Arcila Maria, Halpern Allan C, Hollmann Travis, Berger Michael F, Busam Klaus |
|
Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma.
Oncotarget 2015 Sep . Gray Elin S, Rizos Helen, Reid Anna L, Boyd Suzanah C, Pereira Michelle R, Lo Johnny, Tembe Varsha, Freeman James, Lee Jenny H J, Scolyer Richard A, Siew Kelvin, Lomma Chris, Cooper Adam, Khattak Muhammad A, Meniawy Tarek M, Long Georgina V, Carlino Matteo S, Millward Michael, Ziman Melan |
|
Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas.
Nature genetics 2015 Sep 47 (9): 996-1002. Krauthammer Michael, Kong Yong, Bacchiocchi Antonella, Evans Perry, Pornputtapong Natapol, Wu Cen, McCusker James P, Ma Shuangge, Cheng Elaine, Straub Robert, Serin Merdan, Bosenberg Marcus, Ariyan Stephan, Narayan Deepak, Sznol Mario, Kluger Harriet M, Mane Shrikant, Schlessinger Joseph, Lifton Richard P, Halaban Ru |
|
Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway.
Nature genetics 2015 Sep . Shain A Hunter, Garrido Maria, Botton Thomas, Talevich Eric, Yeh Iwei, Sanborn J Zachary, Chung Jongsuk, Wang Nicholas J, Kakavand Hojabr, Mann Graham J, Thompson John F, Wiesner Thomas, Roy Ritu, Olshen Adam B, Gagnon Alexander, Gray Joe W, Huh Nam, Hur Joe S, Busam Klaus J, Scolyer Richard A, Cho Raymond J, Murali Rajmohan, Bastian Boris |
|
Mutation scanning of BRAF, NRAS, KIT, and GNAQ/GNA11 in oral mucosal melanoma: a study of 57 cases.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2015 Sep . Lyu Jiong, Wu Yunteng, Li Chaojun, Wang Runxiang, Song Hao, Ren Guoxin, Guo W |
|
Clinical characteristics associated with BRAF, NRAS and KIT mutations in Japanese melanoma patients.
Journal of dermatological science 2015 Jul . Sakaizawa Kaori, Ashida Atsuko, Uchiyama Aya, Ito Takamichi, Fujisawa Yasuhiro, Ogata Dai, Matsushita Shigeto, Fujii Kazuyasu, Fukushima Satoshi, Shibayama Yoshitsugu, Hatta Naohito, Takenouchi Tatsuya, Uehara Jiro, Okuyama Ryuhei, Yamazaki Naoya, Uhara Hisas |
|
Expression of the class 1 histone deacetylases HDAC8 and 3 are associated with improved survival of patients with metastatic melanoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2015 Jul 28 (7): 884-94. Wilmott James S, Colebatch Andrew J, Kakavand Hojabr, Shang Ping, Carlino Matteo S, Thompson John F, Long Georgina V, Scolyer Richard A, Hersey Pet |
|
Mutational dichotomy in desmoplastic malignant melanoma corroborated by multigene panel analysis.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2015 Jul 28 (7): 895-903. Jahn Stephan W, Kashofer Karl, Halbwedl Iris, Winter Gerlinde, El-Shabrawi-Caelen Laila, Mentzel Thomas, Hoefler Gerald, Liegl-Atzwanger Bernadet |
|
The role of BRAF mutations in primary melanoma growth rate and survival.
The British journal of dermatology 2015 Jul 173 (1): 76-82. Mar V J, Liu W, Devitt B, Wong S Q, Dobrovic A, McArthur G A, Wolfe R, Kelly J |
|
Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.
JAMA oncology 2015 Jun 1 (3): 359-68. Thomas Nancy E, Edmiston Sharon N, Alexander Audrey, Groben Pamela A, Parrish Eloise, Kricker Anne, Armstrong Bruce K, Anton-Culver Hoda, Gruber Stephen B, From Lynn, Busam Klaus J, Hao Honglin, Orlow Irene, Kanetsky Peter A, Luo Li, Reiner Anne S, Paine Susan, Frank Jill S, Bramson Jennifer I, Marrett Lorraine D, Gallagher Richard P, Zanetti Roberto, Rosso Stefano, Dwyer Terence, Cust Anne E, Ollila David W, Begg Colin B, Berwick Marianne, Conway Kathleen, |
|
Clinicopathological characteristics and mutation profiling in primary cutaneous melanoma.
The American Journal of dermatopathology 2015 May 37 (5): 389-97. Yaman Banu, Akalin Taner, Kandilo?lu Gül? |
|
High-throughput oncogene mutation profiling shows demographic differences in BRAF mutation rates among melanoma patients.
Melanoma research 2015 Mar . van den Hurk Karin, Balint Balazs, Toomey Sinead, O'Leary Patrick C, Unwin Louise, Sheahan Kieran, McDermott Enda W, Murphy Ian, van den Oord Joost J, Rafferty Mairin, FitzGerald Dara M, Moran Julie, Cummins Robert, MacEneaney Owen, Kay Elaine W, O'Brien Cathal P, Finn Stephen P, Heffron Cynthia C B B, Murphy Michelle, Yela Ruben, Power Derek G, Regan Padraic J, McDermott Clodagh M, O'Keeffe Allan, Orosz Zsolt, Donnellan Paul P, Crown John P, Hennessy Bryan T, Gallagher William |
|
Impact of NRAS Mutations for Patients with Advanced Melanoma Treated with Immune Therapies.
Cancer immunology research 2015 Mar 3 (3): 288-95. Johnson Douglas B, Lovly Christine M, Flavin Marisa, Panageas Katherine S, Ayers Gregory D, Zhao Zhiguo, Iams Wade T, Colgan Marta, DeNoble Sarah, Terry Charles R, Berry Elizabeth G, Iafrate A John, Sullivan Ryan J, Carvajal Richard D, Sosman Jeffrey |
|
Prevalence of BRAF and NRAS mutations in cutaneous melanoma patients in Taiwan.
Journal of the Formosan Medical Association = Taiwan yi zhi 2015 Mar . Sheen Yi-Shuan, Liao Yi-Hua, Liau Jau-Yu, Lin Ming-Hsien, Hsieh Yi-Chun, Jee Shiou-Hwa, Chu Chia- |
|
TERT promoter mutations in sinonasal malignant melanoma: a study of 49 cases.
Melanoma research 2015 Mar . Jangard Mattias, Zebary Abdlsattar, Ragnarsson-Olding Boel, Hansson Joh |
|
Increased levels of ?-catenin, LEF-1, and HPA-1 correlate with poor prognosis for acral melanoma with negative BRAF and NRAS mutation in BRAF exons 11 and 15 and NRAS exons 1 and 2.
DNA and cell biology 2015 Jan 34 (1): 69-77. Xu Sanxiong, Yang Zuozhang, Zhang Jinyu, Jiang Yongxin, Chen Yongbin, Li Hongjun, Liu Xuefeng, Xu Da, Chen Yanjin, Yang Yihao, Zhang Ya, Li Dongxu, Xia Junfe |
|
The immune-related role of BRAF in melanoma.
Molecular oncology 2015 Jan 9 (1): 93-104. Tomei Sara, Bedognetti Davide, De Giorgi Valeria, Sommariva Michele, Civini Sara, Reinboth Jennifer, Al Hashmi Muna, Ascierto Maria Libera, Liu Qiuzhen, Ayotte Ben D, Worschech Andrea, Uccellini Lorenzo, Ascierto Paolo A, Stroncek David, Palmieri Giuseppe, Chouchane Lotfi, Wang Ena, Marincola Francesco |
|
Whole exome sequencing identifies a recurrent RQCD1 P131L mutation in cutaneous melanoma.
Oncotarget 2015 Jan 6 (2): 1115-27. Wong Stephen Q, Behren Andreas, Mar Victoria J, Woods Katherine, Li Jason, Martin Claire, Sheppard Karen E, Wolfe Rory, Kelly John, Cebon Jonathan, Dobrovic Alexander, McArthur Grant |
|
Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas.
Journal of translational medicine 2015 13 37. Manca Antonella, Lissia Amelia, Capone Mariaelena, Ascierto Paolo A, Botti Gerardo, Caracò Corrado, Stanganelli Ignazio, Colombino Maria, Sini MariaCristina, Cossu Antonio, Palmieri Giusep |
|
Focused molecular analysis of small cell lung cancer: feasibility in routine clinical practice.
BMC research notes 2015 8 688. Abdelraouf Fatma, Sharp Adam, Maurya Manisha, Mair Debbie, Wotherspoon Andrew, Leary Alex, Gonzalez de Castro David, Bhosle Jaishree, Nassef Ayatallah, Gaafar Taghrid, Popat Sanjay, Yap Timothy A, O'Brien Ma |
|
The prevalence of somatic RAS mutations in medullary thyroid cancer - a Polish population study.
Endokrynologia Polska 2015 66 (2): 121-5. Oczko-Wojciechowska Malgorzata, Pfeifer Aleksandra, Rusinek Dagmara, Pawlaczek Agnieszka, Zebracka-Gala Jadwiga, Kowalska Malgorzata, Kowal Monika, Swierniak Michal, Krajewska Jolanta, Gawlik Tomasz, Chmielik Ewa, Czarniecka Agnieszka, Szpak-Ulczok Sylwia, Jarz?b Barba |
|
Molecular characterization and patient outcome of melanoma nodal metastases and an unknown primary site.
Annals of surgical oncology 2014 Dec 21 (13): 4317-23. Gos Aleksandra, Jurkowska Monika, van Akkooi Alexander, Robert Caroline, Kosela-Paterczyk Hanna, Koljenovi? Senada, Kamsukom Nyam, Michej Wanda, Jeziorski Arkadiusz, Pluta Piotr, Verhoef Cornelis, Siedlecki Janusz A, Eggermont Alexander M M, Rutkowski Pio |
|
Clinical and pathological associations of the activating RAC1 P29S mutation in primary cutaneous melanoma.
Pigment cell & melanoma research 2014 Nov 27 (6): 1117-25. Mar Victoria J, Wong Stephen Q, Logan Aleksandra, Nguyen Trung, Cebon Jonathan, Kelly John W, Wolfe Rory, Dobrovic Alexander, McLean Catriona, McArthur Grant |
|
Association between BRAFV600E and NRASQ61R mutations and clinicopathologic characteristics, risk factors and clinical outcome of primary invasive cutaneous melanoma.
Cancer causes & control : CCC 2014 Oct 25 (10): 1379-86. Wu Shaowei, Kuo Helen, Li Wen-Qing, Canales Alvaro Laga, Han Jiali, Qureshi Abrar |
|
Dermoscopic criteria associated with BRAF and NRAS mutation status in primary cutaneous melanoma.
The British journal of dermatology 2014 Oct 171 (4): 754-9. Pozzobon F C, Puig-Butillé J A, González-Alvarez T, Carrera C, Aguilera P, Alos L, Badenas C, Grichnik J M, Malvehy J, Puig |
|
TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma.
Journal of the National Cancer Institute 2014 Sep 106 (9): 9. Griewank Klaus G, Murali Rajmohan, Puig-Butille Joan Anton, Schilling Bastian, Livingstone Elisabeth, Potrony Miriam, Carrera Cristina, Schimming Tobias, Möller Inga, Schwamborn Marion, Sucker Antje, Hillen Uwe, Badenas Celia, Malvehy Josep, Zimmer Lisa, Scherag André, Puig Susana, Schadendorf Di |
|
Oncogenic mutations in melanomas and benign melanocytic nevi of the female genital tract.
Journal of the American Academy of Dermatology 2014 Aug 71 (2): 229-36. Tseng Diane, Kim Julie, Warrick Andrea, Nelson Dylan, Pukay Marina, Beadling Carol, Heinrich Michael, Selim Maria Angelica, Corless Christopher L, Nelson Kel |
|
A meta-analysis of somatic mutations from next generation sequencing of 241 melanomas: a road map for the study of genes with potential clinical relevance.
Molecular cancer therapeutics 2014 Jul 13 (7): 1918-28. Xia Junfeng, Jia Peilin, Hutchinson Katherine E, Dahlman Kimberly B, Johnson Douglas, Sosman Jeffrey, Pao William, Zhao Zhongmi |
|
Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanoma.
British journal of cancer 2014 Jul 111 (2): 292-9. Carlino M S, Haydu L E, Kakavand H, Menzies A M, Hamilton A L, Yu B, Ng C C, Cooper W A, Thompson J F, Kefford R F, O'Toole S A, Scolyer R A, Long G |
|
H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features: data from a multi-institutional series.
The Journal of clinical endocrinology and metabolism 2014 Jul 99 (7): E1376-80. Oudijk Lindsey, de Krijger Ronald R, Rapa Ida, Beuschlein Felix, de Cubas Aguirre A, Dei Tos Angelo P, Dinjens Winand N M, Korpershoek Esther, Mancikova Veronika, Mannelli Massimo, Papotti Mauro, Vatrano Simona, Robledo Mercedes, Volante Mar |
|
NRAS mutations are more prevalent than KIT mutations in melanoma of the female urogenital tract--a study of 24 cases from the Netherlands.
Gynecologic oncology 2014 Jul 134 (1): 10-4. van Engen-van Grunsven Adriana C H, Küsters-Vandevelde Heidi V N, De Hullu Joanne, van Duijn Lucette M, Rijntjes Jos, Bovée Judith V M G, Groenen Patricia J T A, Blokx Willeke A |
|
Correlation of somatic mutations and clinical outcome in melanoma patients treated with Carboplatin, Paclitaxel, and sorafenib.
Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Jun 20 (12): 3328-37. Wilson Melissa A, Zhao Fengmin, Letrero Richard, D'Andrea Kurt, Rimm David L, Kirkwood John M, Kluger Harriet M, Lee Sandra J, Schuchter Lynn M, Flaherty Keith T, Nathanson Katherine |
|
Molecular profiling of small cell lung cancer in a Japanese cohort.
Lung cancer (Amsterdam, Netherlands) 2014 May 84 (2): 139-44. Wakuda Kazushige, Kenmotsu Hirotsugu, Serizawa Masakuni, Koh Yasuhiro, Isaka Mitsuhiro, Takahashi Shoji, Ono Akira, Taira Tetsuhiko, Naito Tateaki, Murakami Haruyasu, Mori Keita, Endo Masahiro, Nakajima Takashi, Ohde Yasuhisa, Takahashi Toshiaki, Yamamoto Nobuyu |
|
Melanomas of unknown primary frequently harbor TERT-promoter mutations.
Melanoma research 2014 Apr 24 (2): 131-6. Egberts Friederike, Krüger Sandra, Behrens Hans M, Bergner Inka, Papaspyrou Giorgios, Werner Jochen A, Alkatout Ibrahim, Haag Jochen, Hauschild Axel, Röcken Christo |
|
Metastatic melanoma of unknown primary resembles the genotype of cutaneous melanomas.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2014 Jan 25 (1): 246-50. Egberts F, Bergner I, Krüger S, Haag J, Behrens H M, Hauschild A, Röcken |
|
Clonal architectures and driver mutations in metastatic melanomas.
PloS one 2014 9 (11): e111153. Ding Li, Kim Minjung, Kanchi Krishna L, Dees Nathan D, Lu Charles, Griffith Malachi, Fenstermacher David, Sung Hyeran, Miller Christopher A, Goetz Brian, Wendl Michael C, Griffith Obi, Cornelius Lynn A, Linette Gerald P, McMichael Joshua F, Sondak Vernon K, Fields Ryan C, Ley Timothy J, Mulé James J, Wilson Richard K, Weber Jeffrey |
|
Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.
International journal of clinical and experimental pathology 2014 7 (9): 5927-39. Kleist Britta, Kempa Marcel, Novy Michael, Oberkanins Christian, Xu Li, Li Guojun, Loland Christiane, Poetsch Micae |
|
Oncogenic GNAQ and GNA11 mutations in uveal melanoma in Chinese.
PloS one 2014 9 (10): e109699. Xu Xiaolin, Wei Wen Bin, Li Bin, Gao Fei, Zhang Zhibao, Jonas Jost |
|
Large-scale analysis of PDGFRA mutations in melanomas and evaluation of their sensitivity to tyrosine kinase inhibitors imatinib and crenolanib.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Dec 19 (24): 6935-42. Dai Jie, Kong Yan, Si Lu, Chi Zhihong, Cui Chuanliang, Sheng Xinan, Mao Lili, Li Siming, Lian Bin, Yang Ruifeng, Liu Shujing, Xu Xiaowei, Guo J |
|
Clinical characteristics and outcomes with specific BRAF and NRAS mutations in patients with metastatic melanoma.
Cancer 2013 Nov 119 (21): 3821-9. Bucheit Amanda D, Syklawer Erica, Jakob John A, Bassett Roland L, Curry Jonathan L, Gershenwald Jeffrey E, Kim Kevin B, Hwu Patrick, Lazar Alexander J, Davies Michael |
|
The clinical significance of BRAF and NRAS mutations in a clinic-based metastatic melanoma cohort.
The British journal of dermatology 2013 Nov 169 (5): 1049-55. Ekedahl H, Cirenajwis H, Harbst K, Carneiro A, Nielsen K, Olsson H, Lundgren L, Ingvar C, Jönsson |
|
BRAF/NRAS wild-type melanomas have a high mutation load correlating with histologic and molecular signatures of UV damage.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Sep 19 (17): 4589-98. Mar Victoria J, Wong Stephen Q, Li Jason, Scolyer Richard A, McLean Catriona, Papenfuss Anthony T, Tothill Richard W, Kakavand Hojabr, Mann Graham J, Thompson John F, Behren Andreas, Cebon Jonathan S, Wolfe Rory, Kelly John W, Dobrovic Alexander, McArthur Grant |
|
Identification of anaplastic lymphoma kinase break points and oncogenic mutation profiles in acral/mucosal melanomas.
Pigment cell & melanoma research 2013 Sep 26 (5): 646-53. Niu Hai-Tao, Zhou Qi-Ming, Wang Fang, Shao Qiong, Guan Yuan-Xiang, Wen Xi-Zhi, Chen Li-Zhen, Feng Qi-Sheng, Li Wei, Zeng Yi-Xin, Zhang Xiao-S |
|
Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 Sep 31 (26): 3182-90. Hodi F Stephen, Corless Christopher L, Giobbie-Hurder Anita, Fletcher Jonathan A, Zhu Meijun, Marino-Enriquez Adrian, Friedlander Philip, Gonzalez Rene, Weber Jeffrey S, Gajewski Thomas F, O'Day Steven J, Kim Kevin B, Lawrence Donald, Flaherty Keith T, Luke Jason J, Collichio Frances A, Ernstoff Marc S, Heinrich Michael C, Beadling Carol, Zukotynski Katherine A, Yap Jeffrey T, Van den Abbeele Annick D, Demetri George D, Fisher David |
|
KIT, NRAS and BRAF mutations in sinonasal mucosal melanoma: a study of 56 cases.
British journal of cancer 2013 Aug 109 (3): 559-64. Zebary A, Jangard M, Omholt K, Ragnarsson-Olding B, Hansson |
|
KIT, NRAS, BRAF and PTEN mutations in a sample of Swedish patients with acral lentiginous melanoma.
Journal of dermatological science 2013 Aug . Zebary A, Omholt K, Vassilaki I, Höiom V, Lindén D, Viberg L, Kanter-Lewensohn L, Johansson CH, Hansson J |
|
Melanocytomas of the central nervous system: a clinicopathological and molecular study.
European journal of clinical investigation 2013 Aug 43 (8): 809-15. Wang Hai, Zhang Shu, Wu Chun, Zhang Zhiyuan, Qin Taich |
|
[Characterization of genetic alterations in primary human melanomas carrying BRAF or NRAS mutation].
Magyar onkologia 2013 Jun 57 (2): 96-9. Lázár Viktór |
|
Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Jun 19 (12): 3143-52. Griewank Klaus G, Westekemper Henrike, Murali Rajmohan, Mach Monika, Schilling Bastian, Wiesner Thomas, Schimming Tobias, Livingstone Elisabeth, Sucker Antje, Grabellus Florian, Metz Claudia, Süsskind Daniela, Hillen Uwe, Speicher Michael R, Woodman Scott E, Steuhl Klaus-Peter, Schadendorf Di |
|
Assessment of clinical parameters associated with mutational status in metastatic malignant melanoma: a single-centre investigation of 141 patients.
The British journal of dermatology 2013 Apr 168 (4): 708-16. Schlaak M, Bajah A, Podewski T, Kreuzberg N, von Bartenwerffer W, Wardelmann E, Merkelbach-Bruse S, Büttner R, Mauch C, Kurschat |
|
NRAS and BRAF mutations in cutaneous melanoma and the association with MC1R genotype: findings from Spanish and Austrian populations.
The Journal of investigative dermatology 2013 Apr 133 (4): 1027-33. Hacker Elke, Nagore Eduardo, Cerroni Lorenzo, Woods Susan L, Hayward Nicholas K, Chapman Brett, Montgomery Grant W, Soyer H Peter, Whiteman David |
|
MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study.
The Lancet. Oncology 2013 Mar 14 (3): 249-56. Ascierto Paolo A, Schadendorf Dirk, Berking Carola, Agarwala Sanjiv S, van Herpen Carla Ml, Queirolo Paola, Blank Christian U, Hauschild Axel, Beck J Thaddeus, St-Pierre Annie, Niazi Faiz, Wandel Simon, Peters Malte, Zubel Angela, Dummer Reinha |
|
Genetic alterations in RAS-regulated pathway in acral lentiginous melanoma.
Experimental dermatology 2013 Feb 22 (2): 2. Puig-Butillé JA, Badenas C, Ogbah Z, Carrera C, Aguilera P, Malvehy J, Puig S |
|
Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma.
Journal of translational medicine 2013 11 (1): 202. Colombino Maria, Lissia Amelia, Capone Mariaelena, De Giorgi Vincenzo, Massi Daniela, Stanganelli Ignazio, Fonsatti Ester, Maio Michele, Botti Gerardo, Caracò Corrado, Mozzillo Nicola, Ascierto Paolo A, Cossu Antonio, Palmieri Giusep |
- Page last reviewed:Jul 30, 2019
- Page last updated:Feb 20, 2020
- Content source: